Vivanza Biosciences Limited (BOM:530057)

Vivanza Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	70	70	80	272	752	755
Market Cap Growth	-14.63%	-11.56%	-70.69%	-63.88%	-0.34%	44.45%
Enterprise Value	171	166	140	322	807	784
Last Close Price	1.75	1.76	1.99	6.79	18.80	18.86

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	14.54	17.85	-	49.63	125.69	226.61
PS Ratio	0.06	0.06	1.07	0.97	4.14	6.74
PB Ratio	1.61	1.62	2.01	5.86	18.38	21.61
P/TBV Ratio	2.57	2.59	3.42	9.05	30.62	40.63
P/FCF Ratio	-	-	-	13.54	-	30.59
P/OCF Ratio	-	-	-	13.29	-	30.59

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	0.15	0.14	1.88	1.16	4.44	7.00
EV/EBITDA Ratio	17.63	21.45	-	28.78	70.90	91.48
EV/EBIT Ratio	18.07	22.06	-	29.10	71.06	92.28
EV/FCF Ratio	-	-	-	16.07	-	31.78

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	2.34	2.34	2.18	1.12	1.96	1.58
Debt / EBITDA Ratio	10.49	13.19	-	4.61	7.03	6.43
Debt / FCF Ratio	-	-	-	2.58	-	2.23
Net Debt / Equity Ratio	2.32	2.32	2.15	1.07	1.91	1.56
Net Debt / EBITDA Ratio	10.42	13.11	-29.31	4.44	6.88	6.36
Net Debt / FCF Ratio	-	-3.75	-3.40	2.48	-8.28	2.21
Asset Turnover	-	6.02	0.42	1.33	0.96	0.93
Inventory Turnover	-	39.36	3.20	11.58	6.73	6.26
Quick Ratio	-	0.74	0.89	0.96	0.75	0.83
Current Ratio	-	1.13	1.35	1.29	1.15	1.31
Return on Equity (ROE)	-	9.48%	-15.67%	12.54%	15.78%	10.01%
Return on Assets (ROA)	-	2.44%	-1.06%	3.30%	3.73%	4.42%
Return on Invested Capital (ROIC)	4.65%	4.04%	-2.76%	8.11%	9.09%	10.91%
Return on Capital Employed (ROCE)	-	14.30%	-4.20%	15.10%	20.50%	14.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	6.49%	5.60%	-8.47%	2.02%	0.80%	0.44%
FCF Yield	-38.62%	-38.40%	-31.49%	7.39%	-1.26%	3.27%
Buyback Yield / Dilution	8.04%	-	-2.32%	2.27%	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error